The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

A Senate panel has advanced three sets of bipartisan bills purportedly aimed at reforming the intellectual property (IP) ...